Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
复制标题
DOI:
10.1371/journal.pone.0221481
复制
发表时间:
2019-08-22
期刊:
影响因子:
3.7
通讯作者:
Mahaneem, Mohamed
中科院分区:
文献类型:
--
作者:
Ang, Wen Jeat;Zunaina, Embong;Mahaneem, Mohamed
ObjectiveDetection of vascular endothelial growth factor (VEGF) levels in ocular tissue may perhaps provide insight into the role of VEGF in the pathogenesis and progression of diabetic retinopathy (DR). The aim of this study was to evaluate the levels of VEGF in tears and serum amongst type 2 diabetes mellitus (DM) patients.MethodsA comparative cross-sectional study was conducted between August 2016 and May 2018 involving type 2 DM patients with no DR, non-proliferative DR (NPDR), and proliferative DR (PDR). Tear samples were collected using no.41 Whatman filter paper (Schirmer strips) and 5 mL blood samples were drawn by venous puncture. VEGF levels in tears and serum were measured by enzyme-linked immunosorbent assay.ResultsA total of 88 type 2 DM patients (no DR: 30 patients, NPDR: 28 patients, PDR: 30 patients) were included in the study. Mean tear VEGF levels were significantly higher in the NPDR and PDR groups (114.4 SD 52.5 pg/mL and 150.8 SD 49.7 pg/mL, respectively) compared to the no DR group (40.4 SD 26.5 pg/mL, p